The average one-year price target for LifeMD (NasdaqGM:LFMD) has been revised to $9.44 / share. This is a decrease of 28.16% ...
LifeMD's fair value estimate has been trimmed from roughly $10.63 to $9.25 per share as analysts digest softer Q3 results and a reset 2025 outlook. A slightly higher discount rate, now about 8.26% ...
HIMS grows its telehealth-to-prescription model with new offerings in weight loss, hormone care and diagnostics.
Jack Hampton says his wake-up call came on his 40th birthday, when he felt like he was "beginning to die" after years of obesity ...
Several analyst firms adjusted their price targets for LifeMD. H.C. Wainwright lowered its price target to $9.00 while maintaining a Buy rating, and BTIG adjusted its target to $10.00, also ...
NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (LFMD) (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced it has been recognized on ...
LifeMD (LFMD) grabbed investor attention after third-quarter results came in below expectations, prompting the company to sharply lower its revenue outlook for 2025. The announcement came at the same ...
Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Investing.com - Cantor Fitzgerald has reiterated its Overweight rating and $15.00 price target on LifeMD Inc (NASDAQ:LFMD), representing a 217% upside from the current price of $4.73. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback